Literature DB >> 19958793

Increased anxiety-like behavior of rats during amphetamine withdrawal is reversed by CRF2 receptor antagonism.

Shawn M Vuong1, Harvey A Oliver, Jamie L Scholl, Kathryn M Oliver, Gina L Forster.   

Abstract

Withdrawal from psychostimulants increases anxiety states, and amphetamine-treated rats show increased CRF(2) receptors in the serotonergic cell body region, the dorsal raphe nucleus (dRN). In the current study, amphetamine (2.5 mg/kg, i.p., 14 days) pre-treated rats spent less time in open arms of the elevated plus maze compared saline pre-treated rats at both 24h or 2 weeks of withdrawal, and CRF(2) receptor antagonism (ASV-30; 2 microg/0.5 microl) within the dRN reversed the effects of amphetamine withdrawal on anxiety-like behavior. Overall, results suggest that CRF(2) receptor antagonism may be a novel pharmacological target for anxiety states during drug withdrawal. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19958793      PMCID： PMC2821976          DOI： 10.1016/j.bbr.2009.11.036

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN： 0166-4328            Impact factor:   3.332


  20 in total

Review 1.  The role of corticotropin-releasing factor in drug addiction.

Authors:  Z Sarnyai; Y Shaham; S C Heinrichs
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

2.  Differential expression of 5HT-1A, alpha 1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus.

Authors:  Heidi E W Day; Benjamin N Greenwood; Sayamwong E Hammack; Linda R Watkins; Monika Fleshner; Steven F Maier; Serge Campeau
Journal:  J Comp Neurol       Date:  2004-06-28       Impact factor: 3.215

3.  Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats.

Authors:  A M Basso; M Spina; J Rivier; W Vale; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1999-07       Impact factor: 4.530

4.  Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala.

Authors:  Z Merali; J McIntosh; P Kent; D Michaud; H Anisman
Journal:  J Neurosci       Date:  1998-06-15       Impact factor: 6.167

Review 5.  The neurobiology and control of anxious states.

Authors:  Mark J Millan
Journal:  Prog Neurobiol       Date:  2003-06       Impact factor: 11.685

6.  Corticotropin-releasing factor receptor antagonism within the dorsal raphe nucleus reduces social anxiety-like behavior after early-life social isolation.

Authors:  Jodi Lukkes; Shawn Vuong; Jamie Scholl; Harvey Oliver; Gina Forster
Journal:  J Neurosci       Date:  2009-08-12       Impact factor: 6.167

7.  Intracerebroventricular administration of urotensin II promotes anxiogenic-like behaviors in rodents.

Authors:  Yoshio Matsumoto; Michiko Abe; Takuya Watanabe; Yuka Adachi; Takahiko Yano; Hideki Takahashi; Tsukasa Sugo; Masaaki Mori; Chieko Kitada; Tsutomu Kurokawa; Masahiko Fujino
Journal:  Neurosci Lett       Date:  2004-03-25       Impact factor: 3.046

8.  Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats.

Authors:  Z Sarnyai; E Bíró; J Gardi; M Vecsernyés; J Julesz; G Telegdy
Journal:  Brain Res       Date:  1995-03-27       Impact factor: 3.252

9.  Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats.

Authors:  G C Harris; G Aston-Jones
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala.

Authors:  J Amat; J P Tamblyn; E D Paul; S T Bland; P Amat; A C Foster; L R Watkins; S F Maier
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590
View more
  27 in total

1.  Dissociation of corticotropin-releasing factor receptor subtype involvement in sensitivity to locomotor effects of methamphetamine and cocaine.

Authors:  William J Giardino; Gregory P Mark; Mary P Stenzel-Poore; Andrey E Ryabinin
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

2.  Diazepam reverses increased anxiety-like behavior, social behavior deficit, and dopamine dysregulation following withdrawal from acute amphetamine.

Authors:  Millie Rincón-Cortés; Kimberly G Gagnon; Hannah K Dollish; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2018-06-18       Impact factor: 7.853

3.  Withdrawal from chronic exposure to amphetamine, but not nicotine, leads to an immediate and enduring deficit in motivated behavior without affecting social interaction in rats.

Authors:  Andre Der-Avakian; Athina Markou
Journal:  Behav Pharmacol       Date:  2010-07       Impact factor: 2.293

4.  Dissection of corticotropin-releasing factor system involvement in locomotor sensitivity to methamphetamine.

Authors:  W J Giardino; R Pastor; A M J Anacker; E Spangler; D M Cote; J Li; M P Stenzel-Poore; T J Phillips; A E Ryabinin
Journal:  Genes Brain Behav       Date:  2010-09-30       Impact factor: 3.449

5.  Serotonergic responses to stress are enhanced in the central amygdala and inhibited in the ventral hippocampus during amphetamine withdrawal.

Authors:  Hao Li; Jamie L Scholl; Wenyu Tu; James E Hassell; Michael J Watt; Gina L Forster; Kenneth J Renner
Journal:  Eur J Neurosci       Date:  2014-09-19       Impact factor: 3.386

6.  Chronic amphetamine treatment enhances corticotropin-releasing factor-induced serotonin release in the amygdala.

Authors:  Jamie L Scholl; Shawn M Vuong; Gina L Forster
Journal:  Eur J Pharmacol       Date:  2010-07-23       Impact factor: 4.432

7.  Influence of chronic amphetamine treatment and acute withdrawal on serotonin synthesis and clearance mechanisms in the rat ventral hippocampus.

Authors:  Jeffrey L Barr; Jamie L Scholl; Rajeshwari R Solanki; Michael J Watt; Christopher A Lowry; Kenneth J Renner; Gina L Forster
Journal:  Eur J Neurosci       Date:  2012-11-14       Impact factor: 3.386

Review 8.  Stress-related neuropeptides and addictive behaviors: beyond the usual suspects.

Authors:  Jesse R Schank; Andrey E Ryabinin; William J Giardino; Roberto Ciccocioppo; Markus Heilig
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

9.  Abstinence from repeated amphetamine treatment induces depressive-like behaviors and oxidative damage in rat brain.

Authors:  Yi Che; Yong-Hua Cui; Hua Tan; Ana C Andreazza; L Trevor Young; Jun-Feng Wang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-01       Impact factor: 4.530

10.  Amphetamine withdrawal differentially affects hippocampal and peripheral corticosterone levels in response to stress.

Authors:  Brenna Bray; Jamie L Scholl; Wenyu Tu; Michael J Watt; Kenneth J Renner; Gina L Forster
Journal:  Brain Res       Date:  2016-05-18       Impact factor: 3.252
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.